pre-ipo
Stage
About
BioDlink is a contract development and manufacturing organization (CDMO) based in Suzhou, China, specializing in the development and commercial GMP manufacturing of biological drugs including monoclonal antibodies and antibody-drug conjugates (ADCs).
Explore BioDlink's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.